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Background: The activity of several well-known anti-malarials, including chloroquine (CQ), is attributed to their
ability to inhibit the formation of haemozoin (Hz) in the malaria parasite. The formation of inert Hz, or malaria
pigment, from toxic haem acquired from the host red blood cell of the parasite during haemoglobin digestion
represents a pathway essential for parasite survival. Inhibition of this critical pathway therefore remains a desirable
target for novel anti-malarials. A recent publication described the results of a haem fractionation assay used to
directly determine haemoglobin, free haem and Hz in Plasmodium falciparum inoculated with CQ. CQ was shown
to cause a dose-dependent increase in cellular-free haem that was correlated with decreased parasite survival. The
method provided valuable information but was limited due to its low throughput and high demand on parasite
starting material. Here, this haem fractionation assay has been successfully adapted to a higher throughput method
in 24-well plates, significantly reducing lead times and starting material volumes.
Methods: All major haem species in P. falciparum trophozoites, isolated through a series of cellular fractionation
steps were determined spectrophotometrically in aqueous pyridine (5 % v/v, pH 7.5) as a low spin complex with
haematin. Cell counts were determined using a haemocytometer and a rapid novel fluorescent flow cytometry
method.
Results: A higher throughput haem fractionation assay in 24-well plates, containing at most ten million trophozoites
was validated against the original published method using CQ and its robustness was confirmed. It provided a
minimum six-fold improvement in productivity and 24-fold reduction in starting material volume. The assay was
successfully applied to amodiaquine (AQ), which was shown to inhibit Hz formation, while the antifolate pyrimethamine
(PYR) and the mitochondrial electron transporter inhibitor atovaquone (Atov) demonstrated no increase in toxic cellular
free haem.
Conclusions: This higher throughput cellular haem fractionation assay can easily be applied to novel anti-malarials
with a significantly decreased lead time, providing a valuable tool with which to probe the mechanisms of action
of both new and established anti-malarials.
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The inhibition of the haem detoxification pathway in the
malaria parasite, Plasmodium falciparum remains an at-
tractive drug target with several important anti-malarials,
primarily quinolines proposed to target it [1]. During its
asexual erythrocytic cycle, free haem, derived from the di-
gestion of host red blood cell haemoglobin (62 ± 13 −%) is
autoxidized to poisonous haematin (Fe(III)PPIX), predom-
inantly in the metabolically active trophozoite [2]. In an
early study Ginsburg et al. detected an increase in mem-
brane associated haem upon CQ and amodiaquine (AQ)
treatment of cultured P. falciparum, but recovery of hae-
mozoin in drug-free controls in this study was very low,
with only 20–30 % detected [3]. In a subsequent study it
was shown that the overwhelming majority of this re-
leased haem (up to 95 %) is efficiently sequestered into
inert crystalline haemozoin (Hz) within the parasite’s
acidic digestive vacuole. Transmission electron micros-
copy (TEM) with electron energy loss spectroscopy
(EELS) used to map the distribution of elemental Fe in
mature trophozoite-infected erythrocytes (chloroquine
(CQ) sensitive, D10 strain), confirmed Hz associated Fe is
concentrated in the acidic digestive vacuole with very little
Fe in the cytosol [2]. Hz formation has been shown to be
closely associated with lipids [4]. Recently, neutral lipids
associated with Hz were shown to mediate β-haematin
(BH, synthetic Hz) formation under physiological condi-
tions at rates analogous to parasite Hz formation [5]. This
process of cellular lipid mediated Hz formation is mim-
icked synthetically in a detergent-mediated assay which
substitutes neutral lipids for the lipophilic detergent NP-
40 [6]. This assay has been applied as a high throughput
screening tool and identified several novel scaffolds cap-
able of inhibiting Hz formation [7, 8]. The Hz inhibition
pathway remains a favourable drug target despite resist-
ance to known quinolines and related drugs which have
been attributed to mutations in the parasite’s ‘chloroquine
resistance transporter’ (PfCRT) and other digestive
vacuole membrane proteins [9]. In comparison to CQ-
sensitive strains (CQS), resistant parasites have been
shown to accumulate up to ten times less CQ in the di-
gestive vacuole, falling outside the effective therapeutic
range for CQ [10]. The formation of Hz is unaffected
by PfCRT mutations and so Hz inhibitors remain one
of the most successful classes of anti-malarials to date.
The use of detergent-based screening methods as a
synthetic measure of the ability of a compound to inhibit
the formation of BH is routinely used to identify BH in-
hibitors [8, 11]. This method has been translated into an
analogous process in malaria parasites cultured in vitro,
the haem fractionation assay, a method capable of directly
measuring haem species in CQS P. falciparum [12]. Ori-
ginally applied to CQ, this cellular fractionation technique
colorimetrically measures haem as Fe(III)haem-pyridinecomplex based on a previously published method by Nco-
kazi and Egan in which it was shown that in a mixture of
BH and haematin, the latter forms a low-spin complex
with aqueous pyridine (5 % v/v, pH 7.5) without disturbing
BH [13]. Using the cellular haem fractionation assay, CQ
was shown to cause a dose-dependent increase in ‘free’
haem (i.e., labile haem that can be solubilized with deter-
gent), along with a decrease in Hz correlated to the sur-
vival of P. falciparum cells. TEM with EELS of CQ-treated
cells showed a redistribution of Fe from the digestive
vacuole into the parasite cytoplasm [12]. The method pro-
vided valuable information, successfully demonstrating
the ability of CQ to inhibit cellular Hz formation. Due to
its protracted nature, however, it could not easily be ex-
tended to other drugs. Here, a modified technique de-
signed to increase output and reduce material costs is
described in detail. Performed in 24-well plates, multiple
drug concentrations can be evaluated in one session with
relatively low amounts of parasite starting material. At
minimum results can be obtained for two compounds per
week, a significant improvement in output over the previ-
ous method, which produced results for one compound
every 2 months. The method was successfully validated
against the original haem fractionation assay performed in
flasks using CQ. This validated method was applied to
three clinically relevant anti-malarials covering a broad
spectrum of mechanisms of actions: the 4-aminoquinoline
AQ which like CQ has been shown to inhibit BH forma-
tion, the non-BH inhibiting antifolate pyrimethamine
(PYR) [7] and finally the non-BH inhibiting anti-malarial
atovaquone (Atov). While initial results for Atov showed
an unanticipated increase in the percentage of free haem
with increasing Atov concentration, the total amount of
haem iron per cell was found to be significantly less in
cells treated with Atov. This corresponds to unchanged
free haem per cell with increasing Atov concentration.
This example with Atov demonstrates the importance of
establishing the total amount of haem iron per cell, a cal-
culation which requires the determination of the cell
count in each well of the 24-well plate. Cell counts were
determined using a haemocytometer and flow cytometry
based method with fluorescent cell staining [14–19]. Ac-
quiring cell counts for a large number of samples with a
haemocytometer proved a tedious process, as a result
counting was also performed with a novel flow cytometry
method using SYBR green I fluorescent staining of iso-
lated cells. Over the course of the 48 h lifecycle of the
parasite the amount of DNA increases as the parasite ma-
tures from early rings to multi-nucleated schizonts, trans-
lating to an increase in the SYBR green I fluorescence
signal as a result of binding to double stranded parasite
DNA [19]. SYBR green I was specifically chosen due to its
low binding affinity for RNA and preference for double
stranded DNA over single stranded DNA [20]. In addition
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cytometry method can also provide important information
about morphological changes in the presence of cells
treated with anti-malarials.
The method described here is a modified version of an
established technique which details the increased output
of a previously published assay allowing for the deter-
mination of haem species spectroscopically in isolated P.
falciparum trophozoites.Methods
Unless otherwise stated, all materials used were obtained
from Sigma Life Sciences.In vitro culture of Plasmodium falciparum parasites
A CQS strain of P. falciparum, D10, was used through-
out this study and cultured using a modified method of
Trager and Jensen [21]. Briefly, parasites were main-
tained in fresh type O+ human erythrocytes in medium
containing 10.4 g/l RPMI 1640 with glutamine (and
without NaHCO3), 4 g/l glucose, 6 g/l HEPES, 0.088 g/l
hypoxanthine, 1.2 ml/l gentamycin and 5 g/l Albumax
II (GIBCO). Directly before use, 8.4 ml of 5 % (w/v)
NaHCO3 was added to 200 ml medium. Cultures were
kept at 37 °C in 200-ml flat-bottom flasks under a gas
environment of 3 % O2, 4 % CO2, and N2. The integrity
of the culture was monitored daily using 10 % (v/v)
Giemsa (Merck) stained slides. Synchronization was
maintained by treating with five volumes of 5 % (w/v)
sorbitol for 10 min on ring days. Post synchronisation,
cultures were centrifuged at 750 rcf for 5 min and the
layer of debris corresponding to lysed cells and the as-
sociated Hz was carefully removed from the culture by
aspiration.Biological IC50 determination
In vitro antiplasmodial activity was determined via the
parasite lactate dehydrogenase assay using a modified
method described by Makler et al., which colorimetri-
cally measures Plasmodium lactate dehydrogenase
[22]. Test samples were prepared to a 20 mg/ml stock
solution in 100 % dimethyl sulfoxide (DMSO, Merck)
and stored at −20 °C. On the day of use, samples were
diluted in medium to a starting concentration of
100 μg/ml and serially diluted two-fold in medium in
96-well plates. All samples were tested in triplicate at
ten concentrations, with the lowest concentration be-
ing 0.2 μg/ml. The highest concentration of DMSO to
which the parasites were exposed was 0.5 % (v/v). The
IC50-values were obtained using a non-linear dose–
response curve fitting analysis via Graph Pad Prism
v.4.0 software [23].Haem fractionation assay
Incubation and harvesting
Aliquots of 2 ml of early ring-stage sorbitol synchro-
nized parasites at 5 % parasitaemia and 2 % haematocrit
were added to each well of a 24-well flat-bottom cell cul-
ture plate (Greiner Bio-One). All test compounds were
diluted in medium from the previously prepared 20 mg/
ml stock solution and added to the plate such that the
final volume per well was 2020 μl and the final concen-
trations tested were at several multiples of the com-
pound’s IC50-value. Each concentration was tested as
four replicates and the highest concentration of drug
tested was at 4 × IC50, since beyond this concentration
very few cells remained for harvesting. Plates were incu-
bated at 37 °C in a gas chamber with 3 % O2, 4 % CO2,
and N2. After 32 h, excess supernatant was aspirated and
Giemsa-stained thin smears were prepared on glass
slides at each concentration tested. Each pellet was re-
suspended in 1.9 ml phosphate buffered saline (PBS)
pH 7.5 and transferred to a deep well 2.2 ml rectangular
96-well plate (Labcon). The new plates ensured max-
imum sample recovery in subsequent steps and were es-
sential for further processing. Erythrocytes were lysed
with the addition of 100 μl 1 % (w/v) saponin. After
2 min at 37 °C plates were centrifuged at 750 rcf for
15 min. The supernatant was aspirated and the pellets
washed three times with 0.5 ml PBS to remove all traces
of erythrocyte haemoglobin (Hb). The washed pellet,
corresponding primarily to isolated trophozoites, was re-
suspended, diluted to a final volume of 100 μl with PBS
pH 7.5 and accurately transferred to a round-bottomed,
96-well 0.5 ml plate (Axygen Scientific) referred to as
the stock plate. The stock plate was used to prepare a
second plate for cell counting after which it was frozen
at −80 °C.
Preparation of the counting plate and cell fixation
A counting plate was prepared by adding 10 μl of the
isolated washed trophozoites to the corresponding
wells of a flat-bottomed 96-well plate. The cells were
fixed with 0.125 % (v/v) glutaraldehyde in PBS pH 7.5
to a final volume of 200 μl and refrigerated at 4 °C
overnight.
Haemocytometer counting
Haemocytometer counting was performed on the first
row of each plate only, corresponding to six samples,
each at a different concentration of the drug tested. The
haemocytometer determined cell counts for these six
samples were statistically compared to the cell counts
determined by flow cytometry to test for agreement. Ten
μl of cells from the counting plate were loaded onto a
bright-line haemocytometer and five large squares were
counted after 10 min of settling. The concentration of
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equation 1:
CH ¼ NFDF10;000 ð1Þ
Where:
CH = concentration of cells per ml as determined with
haemocytometer
N = number of cells counted in five fields
F = number of fields counted = 5
DF = dilution factor
Flow cytometry counting
Cell counts for all samples on the counting plate were
determined using flow cytometry [14, 16, 17]. Samples
were analysed on a Becton Dickinson FACSCalibur using
SSC/FL1530nm with CellQuestPro software. Typically
10,000 events were counted for each sample. Samples
were prepared by diluting 100 μl of cells from the count-
ing plate with 800 μl of 1 × SYBR® green I in PBS pH 7.5
and incubating for 30 min in the dark at 37 °C. Next,
each sample was spiked with 100 μl of Trucount™ beads
(Becton Dickinson) such that each sample contained a
known fixed amount of fluorescent beads in a final vol-
ume of 1 ml and was mixed well. The concentration of
cells in the acquisition tube was calculated according to
equation 2:
CF ¼ T=Bð Þ  CB ð2Þ
Where:
CF = concentration of cells per ml as determined with
flow cytometry
T = number of trophozoites gated
B = number of fluorescent beads gatedFig. 1 Dot plots displaying isolated Plasmodium falciparum cells correspon
the fluorescent DNA dye, SYBR green I and the populations correspondingCB = concentration of fluorescent beads in the acquisi-
tion tube per ml (calibrated bead count per ac-
quisition is unique to each lot of tubes obtained
from the supplier)
Trophozoite gates were established by running isolated
trophozoites obtained from a highly synchronous tropho-
zoite culture through the process of harvesting and flow
cytometry analysis as described above. The resulting dot
plot in Fig. 1a represents a population corresponding to
primarily trophozoites. The presence of trophozoites was
confirmed with a 10 % (v/v) Giemsa-stained slide. The
same process was applied to a highly synchronous ring
culture and the resulting dot plot of cell material accrued
as a consequence of the harvesting process (most likely
corresponding to both rings and cell debris) can be seen
in Fig. 1b. A 10 % (v/v) Giemsa-stained slide confirmed
the presence of accumulated cell debris; however it was
difficult to distinguish rings from the debris. The tropho-
zoite population corresponds to cells of a much higher
fluorescent intensity and side scatter (SSC) indicating
more complex cells with more nucleic acid in comparison
to the population of rings and debris with lower fluores-
cent intensity and SSC. The latter population was omitted
during gating and only intact trophozoites were gated and
used to determine cell counts. The population of cells cor-
responding to Fig. 1a and b were assayed for haem as de-
scribed below in the haem fraction assay. Initial gating
was performed with unstained cells to account for autoflu-
orescence. All samples were analysed using FloJo software
version 10 (Tree Star Inc).Haem fractionation
After thawing the stock plate, 50 μl of water was added
and the plate was sonicated for 5 min in an ultrasoundding to trophozoites (a) and rings and cell debris (b) after staining with
to fluorescent Trucount beads
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followed by the addition of 50 μl each of 0.2 M HEPES
buffer pH 7.5 and water. The plate was then centri-
fuged at 3600 rpm for 20 min. Very carefully, without
disturbing the pellet, the supernatant was transferred
to an adjacent set of wells on the same plate. The
supernatant was processed further with 50 μl 4 % SDS,
sonicated for 5 min and then incubated at 37 °C for
30 min. Fifty μl of 0.3 M NaCl and 50 μl of 25 % (v/v)
pyridine in 0.2 M HEPES pH 7.5 were added and
200 μl of the solution was transferred to a flat-
bottomed UV-Star 96-well plate. This fraction corre-
sponds to the Hb fraction.
The pellet was treated with 50 μl water, 50 μl 4 % SDS
and resuspended. The plate was sonicated for 5 min and
incubated at 37 °C for 30 min to solubilize free haem.
This was followed by the addition of 50 μl 0.2 M HEPES
pH 7.5, 50 μl 0.3 M NaCl and 50 μl 25 % pyridine. The
plate was centrifuged at 3700 rpm for 20 min. Very care-
fully without disturbing the pellet, the supernatant was
transferred to an adjacent set of wells on the same plate.
The supernatant was diluted to a final volume of 400 μl
with water. This fraction corresponds to the free haemFig. 2 Flow diagram showing the haem fractionation assay: original flask m
haem fractionation assay is a cellular fractionation technique based on the
haem-pyridine complex with free haem in the presence of Hz [13]. The ori
drug concentration at a time and performing spectroscopic measurements
plates, testing several drug concentrations, four replicates at a time and us
increase in output. Immature ring stage parasitized red blood cells were in
32 h, mature trophozoites were harvested via saponin lysis of erythrocytes.
was measured in the supernatant as a low spin haem-pyridine complex. Th
haem, measured in the supernatant following centrifugation. Hz was meas
treating with pyridinefraction; 200 μl of this solution was transferred to the
flat-bottomed UV-Star 96-well plate, the same plate pre-
viously used for the Hb fraction.
The remaining pellet containing Hz was solubilized in
50 μl of water and 50 μl 0.3 M NaOH. The plate was
sonicated for 15 min and incubated at 37 °C for 30 min
and 50 μl each of 0.2 M HEPES pH 7.5, 0.3 M HCl and
25 % pyridine was added followed by 150 μl water. This
fraction corresponds to the Hz fraction; 200 μl of this
solution was transferred to vacant wells in the flat-
bottomed UV-Star 96-well plate containing the Hb and
free haem fractions. The UV-visible spectra of haem as
Fe(III)haem-pyridine complex was recorded using a
multi-well plate reader (Spectramax 340PC, Molecular
Devices). The absorbance maxima of the Fe(III)haem
pyridine complex in each well was used to calculate the
percentage of each haem species in each sample as the
final volume for each fraction was identical. The proced-
ure is presented graphically in Fig. 2.
Haem standard curve
The total amount of haem in each fraction was quanti-
fied using a haem standard curve prepared from aethod (left) versus increased throughput plate method (right). The
ability of neutral aqueous pyridine to selectively form a low spin
ginal method was performed in 250 ml culture flasks, testing a single
in a cuvette [12]. The modified method was performed in 24-well
ing a multiwell plate reader to record absorbance, resulting in a six-fold
oculated with several different increasing drug concentrations. After
Following hypotonic lysis and centrifugation, SDS treated soluble Hb
e pellet was further treated with SDS and pyridine to solubilize free
ured after solubilizing the pellet in NaOH, neutralizing with HCl and
Table 1 Summary of P-values (unpaired 2-tailed t-test, 95 % CI)
obtained when comparing the counts obtained with the FACS
method to the haemocytometer method at each concentration
of each drug tested
CQ (nM) P AQ (nM) P Atov (nM) P PYR (nM) P
7.5 0.92 12.5 0.12 1 0.75 25 0.13
15 0.68 25 0.56 2 0.92 50 0.12
30 0.32 50 0.056 4 0.69 100 0.087
45 0.89 75 0.28 8 0.83 150 0.11
90 0.96 100 0.061 16 0.23 200 0.86
In all cases the mean count obtained using the haemocytometer did not differ
significantly from the mean count obtained using the FACS method
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in 0.3 M NaOH. Serial dilutions of the standard were
carried out in a 96-well plate with 100 μl 0.3 M NaOH
as a blank. Fifty μl of each of the following solutions
were added to 100 μl of haematin standard: 0.2 M
HEPES pH 7.5, 4 % (w/v) SDS, 0.3 M NaCl, 0.3 M HCl,
25 % pyridine in 0.2 M HEPES pH 7.5 and water. The
visible spectra of haem as Fe(III)haem-pyridine complex
were recorded in a multi-well plate reader. The amount
of haem Fe per cell was calculated by dividing the total
haem Fe in each fraction by the number of cells deter-
mined in each fraction.
Statistical analysis
Bland Altman analysis was used to assess the agreement
between the original haem fractionation method and
modified plate method [24]. For determination of statis-
tical significance of differences in measurements relative
to controls, a two-tailed t-test (95 % CI) was used and is
displayed on graphs using asterisks (* P <0.05; ** P <0.01;
*** P <0.001). In all cases data represent a minimum of
three repeats. All analysis was carried out using GraphPad
Prism version 4.0 software [23].
Results and discussion
Cell counting: haemocytometer versus flow cytometer
Cell counts, required for the determination of the total
amount of haem Fe per cell (reported in fg/cell) were
originally determined manually using a haemocytometer.
This method was found to be slow and tedious when ap-
plied to 24 samples per plate and an alternative, more ef-
ficient method for counting cells was set up using flow
cytometry. Post fixation with glutaraldehyde, cells were
stained with the DNA binding fluorescent dye SYBR
green I, spiked with a fixed number of fluorescent Tru-
count™ beads (Becton Dickinson) and analysed with a
Becton Dickinson FACS Calibur using SSC/FL1530nmFig. 3 Average counts obtained using a haemocytometer (horizontal
stripes) and FACS (vertical stripes) for controls in each experiment.
The mean count obtained using the haemocytometer did not differ
significantly from the mean count obtained using the FACS method
(n = 6, 6), P = 0.876 (unpaired two-tailed t-test, 95 % CI)with CellQuestPro software. Cell counts using flow cy-
tometry were performed on all wells of each 24-well
plate and haemocytometer counts were routinely done
on the first row only of each 24-well plate for compari-
son and to establish agreement between the methods. In
both cases only intact isolated trophozoites were
counted. Flow cytometry is a faster, less subjective
process than haemocytometer counting but is not with-
out limitations. The first issue relates to the accurate
gating of cells. Despite having established a gate specific-
ally for trophozoites (Fig. 1a) which excludes any rings
and cell debris collected during the process of harvesting
(Fig. 1b), an overlap exists where cells which appear as
larger, mature rings have the same SSC and fluorescent
intensity as immature or underdeveloped trophozoites
and it is not possible to distinguish the two, which can
result in an inaccurate trophozoite cell count. The sec-
ond issue is counting aggregates of cells as a single com-
plex cell resulting in undercounting, however this is
largely overcome by mixing samples well duringFig. 4 Absorbance spectra of Hz haem for the ring (gray) and
trophozoite (black) stages obtained from the same culture. The Soret
peak obtained from the ring stage is very weak compared to that
from the trophozoite stage. The maximum content of haemozoin in
the ring culture is 4.2 ± 0.4 % (n = 4) of that in the trophozoites. In
order to detect a significant signal from the ring stage, these
experiments were conducted with 2.5 × 107 parasites
Fig. 5 The Soret band absorbance readings for Hb (a), haem (b) and Hz (c) fractions of a sample spiked with 100 μl of RBCs compared to a
control sample containing 40 μl of 5 % parasitized RBCs under identical conditions. No significant change was seen in the haem levels of the Hb
fraction (P = 0.57), the haem fraction (P = 0.52) or the Hz fraction (P = 0.33) of the sample spiked with 2.5 fold more RBCs than the control
(unpaired two-tailed t-test, 95 % CI, n = 6). Both the control and spiked sample contained 107 parasites and were from the same culture
Table 2 Summary of mean absorbances (n = 6) and P-values
(unpaired 2-tailed t-test, 95 % CI) for the control, a sample
sonicated for 15 min and a sample spiked with Hz
Sample Average absorbance P-value
Control 0.024 ± 0.003 N/A
Sonicated for 15 min 0.021 ± 0.001 0.08
Hz Spiked 0.027 ± 0.006 0.26
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Despite the limitations associated with both counting
methods, it was found there was no statistical difference
between the means as determined by each counting
method (unpaired two-tailed t-test, 95 % CI) for the un-
treated control (Fig. 3). Furthermore, no significant dif-
ference was seen at any concentration of the four drugs
tested (Table 1).
Assessment of the robustness of the assay
In the previous report on the flask method for determin-
ation of haem species in P. falciparum, the method was
not described in detail [12]. In particular, the specificity
of the assay for different haem species in the various
fractions was not investigated with respect to cross-
contamination at each of the fractionation steps. This
has now been addressed in the plate assay.
When cultured parasites are synchronized with sorb-
itol, trophozoites present in the asynchronous culture
are lysed and release their haemozoin. If no precautions
were taken, this haemozoin would be carried into the
synchronized culture used in the assay. To avoid this,
visible pigmented cell debris was removed by aspiration
immediately following sorbitolization. To confirm that
significant quantities of pre-formed haemozoin did not
contaminate the sample, a synchronous culture was sub-
jected to the process of harvesting, followed by the haem
fractionation assay at the ring stage soon after sorbitol
treatment. At this stage of the lifecycle, early rings would
have produced no haemozoin. Consequently, any haem
detected in the haemozoin fraction arises from either
haemozoin carried over during synchronization, or from
a small fraction of trophozoites that survive sorbitol
treatment. Figure 4 shows that the absorbance spectrum
of haem present in this fraction was very low compared
to material isolated from the same culture at the tropho-
zoite stage. The cross contamination from previous cy-
cles was thus at most 4 % (since a portion of the smallabsorbance seen almost certainly arose from trophozo-
ites still present in the culture post synchronization).
Thus, the carry-over of Hz from previous cycles was
found to be negligible.
A second potential source of cross-contamination is
RBC Hb, which is the dominant form of haem in the
total culture at 5 % parasitaemia. Trophozoites isolated
by saponin lysis are accompanied by lysed RBC mem-
branes. The pellet could be contaminated with Hb if the
washing steps are not efficient enough to remove it and
would result in elevated trophozoite Hb readings. The
elevated readings could potentially carry over into subse-
quent fractions. To test this, the 40 μl RBC pellet con-
taining 5 % parasitized cells was spiked with 100 μL of
packed RBCs. This mixture was then subjected to the
usual harvesting and haem fractionation assay and all
the haem species were measured. As shown in Fig. 5,
none of the fractions showed any significant change in
haem levels relative to the unspiked control. This dem-
onstrated that cross-contamination by RBC Hb is not
significant provided that the washing protocol is
followed.
Finally, the ‘free’ haem fraction could potentially be
contaminated as a result of the breakdown of haemozoin
during ultrasound treatment in the presence of SDS.
Two approaches were used to test this. Firstly, the dur-
ation of ultrasound treatment was increased three-fold
to 15 min. No significant change in free haem levels was
detected (Table 2). Secondly, the pellet containing ‘free’
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zoin prior to addition of SDS and ultrasound treatment.
The haemozoin was obtained from the final pellet of a
control experiment isolated prior to addition of NaOH
and doubled the quantity of haemozoin in the sample.
Isolation of ‘free’ haem from this spiked sample showed
no significant difference relative to an unspiked control
(Table 2). This confirmed that haemozoin does not con-
taminate the ‘free’ haem fraction.Fig. 6 Percentage of haem species found in chloroquine-treated trophozo
plate method (d, e, f and h) Hb (a, d), ‘free’ haem (b, e) and Hz (c, f) at incr
haem found in isolated trophozoites. Statistical significance, calculated usin
to the control using asterisks. The parasite survival curve (left axis) was determin
the percentage of ‘free’ haem (right axis) determined by both the original flask
Plots are scaled so that the dotted line in this and subsequent figures corr
the parasite lactate dehydrogenase assay and the midpoint of the ‘free’ ha
in D10 = 19.2 ± 4.2 nMValidation of plate method with CQ
The plate method was validated in CQS D10 P. falcip-
arum inoculated with CQ, since a full dose response
profile was previously reported for CQ using the flask
method at several different concentrations [12], allowing
for direct comparison of results. The effect on all three
haem species was examined and statistically compared
to the previously published data obtained with the ori-
ginal flask method (Fig. 6a, b, c, and g) [12].ites assayed with the original flask method (a, b, c and g) and the new
easing concentrations of CQ are expressed as a percentage of the total
g a two-tailed t-test (error bars showing 95 % CI) is expressed relative
ed using the parasite lactate dehydrogenase assay [22] and is overlaid with
method (g) and new plate method (h) as a function of CQ concentration.
esponds to both the parasite growth inhibition IC50 as determined by
em increase determined using the haem fractionation assay. CQ IC50
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percentage ‘free’ haem with corresponding decrease in
Hz in CQS P. falciparum inoculated with CQ (Fig. 6b, c,
e and f). In both cases the rise in ‘free’ haem mirrors the
decline in the survival curve of the parasite such that at
higher concentrations of ‘free’ haem corresponding
to parasites exposed to high doses of CQ very few
trophozoites survive after the 32-h incubation period
(Fig. 5g, h). Although the trend for both methods is the
same, the modified plate method showed a more muted
response for both the increase in ‘free’ haem and de-
crease in Hz (Fig. 6b, c, e and f ). In the flask method,
the maximum increase in ‘free’ haem was 10.2 % com-
pared to the control, while in the plate method the max-
imum increase in ‘free’ haem compared to the control
was 7.0 %. This is probably attributable to the decreased
absorbance as a result of reduced starting material vol-
umes for each sample, which is in turn associated with
larger errors. Small but significant sample losses which
occur at each fractionation step, as well as sample carry
over during the transfer and separation of the super-
natant and pellets are also likely contributory factors.Fig. 7 Bland Altman plots displaying the differences between the results o
measurement for Hb (a), ‘free’ haem (b) and Hz (c). The dotted lines represe
methods. Outliers were removed using the modified Thompson Tau test bBland Altman analysis was used to statistically com-
pare the two methods with respect to the percentage of
each haem species calculated [24]. For each haem species
the difference in the average of the result obtained with
the flask and modified plate method was plotted against
the mean of the result obtained with each method. The
agreement between the two methods for both ‘free’ haem
(Fig. 7b) and Hz (Fig. 7c) were good, showing narrow
limits of agreement in comparison to the means. Hz how-
ever does show evidence of systematic error for the three
lowest mean percentages, corresponding to cells which
were dosed at 90 nM CQ (greater than four times the IC50
of CQ). This is most likely associated with larger errors
due to poor recovery at high drug concentrations. Hb
(Fig. 7a) showed much broader limits of agreement be-
tween the methods relative to the mean for each set of
measurements. The determination of Hb, specifically in
the plate method was very often associated with large er-
rors owing to the small sample volume used, resulting in
low absorbance values for Hb, which is present in very
small amounts in mature trophozoites. In view of the good
agreement for Hz and especially ‘free’ haem, the higherbtained with the plate method and the flask method at each
nt the upper and lower 95 % limits of agreement between the two
efore analysis. Data are representative of three separate experiments
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ther investigations of its versatility.
Cell counts determined by flow cytometry were used
to determine the amount of haem Fe per trophozoite
(fg/cell) at each dose of CQ. Previous studies on tropho-
zoites isolated using the older flask method with haemo-
cytometer cell counting showed that the total amount of
haem Fe in CQ-treated cells was not statistically differ-
ent to control cells [12]. These results were confirmed in
the current study where it was found that the total haem
Fe in CQ-treated trophozoite cells was statistically indis-
tinguishable from control cells (Fig. 8d). The haem frac-
tionation profiles showing the amount of Hb (Fig. 8a),
‘free’ haem (Fig. 8b) and Hz (Fig. 8c) Fe per trophozoite
with increasing CQ concentration followed the same
trend as the corresponding percentage profiles seen in
Fig. 6d, e and f. Similarly an overlay of the parasite sur-
vival curve with the amount of ‘free’ haem Fe per
trophozoite shows an increase in the amount of ‘free’
haem per cell correlated to cell death (Fig. 8e) with both
graphs intersecting at a point corresponding to 50 %
parasite survival.Fig. 8 Amount of haem Fe per cell (fg) found in chloroquine-treated troph
concentrations of CQ expressed as total amount of haem Fe per isolated tr
tically different to untreated cells (d). Statistical significance, calculated usin
to the control using asterisks. The parasite survival curve was determined u
the total amount of ‘free’ haem Fe per isolated trophozoite as a function oAmodiaquine
The new method was applied to another 4-aminoquinoline,
AQ, which like CQ has also been shown to inhibit BH
formation with the NP-40 detergent mediated BH inhib-
ition assay [7]. Preliminary results for ‘free’ haem per-
formed on parasites treated with AQ at 2.5× the
parasite growth inhibition IC50 showed an increase in
‘free’ haem significantly different to the control [12]. A
full dose response carried out using the plate method
confirmed that AQ, like CQ was a Hz inhibitor causing
a dose related increase in ‘free’ haem accompanying
parasite death (Fig. 9a, b and c). No statistical difference
was found in total haem Fe/trophozoite (fg/cell) between
the control and AQ-treated samples (Fig. 9d). This result
made it possible to use the percentage values of ‘free’
haem (Fig. 9a) and Hz (Fig. 9b) as a direct indication of
the effect of AQ on each of the haem species, as was the
case for CQ (Figs. 6 and 7). The profiles for the amount
of ‘free’ haem Fe/trophozoite and Hz Fe/trophozoite
with increasing AQ concentration (Fig. 9e and f ) mirror
the profiles obtained with the percentage values of the
corresponding haem species (Fig. 9a and b).ozoites (plate method). Hb (a), ‘free’ haem (b) and Hz (c) at increasing
ophozoite (fg/cell). Total haem Fe per cell in the control was not statis-
g a two-tailed t-test (error bars showing 95 % CI) is expressed relative
sing the parasite lactate dehydrogenase assay [22] and is overlaid with
f CQ concentration (e). CQ IC50 in D10 = 19.2 ± 4.2 nM
Fig. 9 Haem fractionation profiles for amodiaquine-treated parasites. The percentages of ‘free’ haem (a) and Hz (b) are shown at increasing
concentrations of AQ. The parasite survival curve for AQ, determined using the parasite lactate dehydrogenase assay [22] overlaid with the
percentage of ‘free’ haem shows a rise in ‘free’ haem with increasing AQ concentration corresponding to decreased parasite survival (c). The total
haem Fe per trophozoite of all AQ-treated cells is not statistically different to untreated cells (d). The amount of ‘free’ haem Fe (e) and Hz Fe (f)
are shown at increasing concentrations of AQ. The parasite survival curve for AQ, overlaid with the amount of ‘free’ haem shows a rise in ‘free’
haem with increasing AQ concentration correlated to decreased parasite survival (G). AQ IC50 in D10 = 21.6 ± 3.0 nM
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The plate method was applied to the non-BH inhibiting
antifolate PYR [7]. Previously used as a negative control,
PYR showed no increase in ‘free’ haem or decrease in
Hz when tested at 2.5× its parasite growth inhibition
IC50 [12]. At higher concentrations of PYR correspond-
ing to 3.5× and 4.5× IC50, the per cent ‘free’ haem
(Fig. 10a) does show a statistically significant increase
compared to the control. This increase in ‘free’ haem is
however not dose related and is not accompanied by a
decrease in per cent Hz (Fig. 10b) which remains con-
stant at all PYR concentrations. Furthermore, the in-
crease in the amount of ‘free’ haem is significant only atthe highest dose. These data are consistent with the fact
that that PYR is not a Hz inhibitor.
Atovaquone
The method was also applied to Atov which shows no
BH inhibition, but has a mechanism of action known to
selectively disrupt mitochondrial electron transport in
the parasite by inhibiting the cytochrome bc1 complex
without affecting host cell mitochondria [25, 26].
Surprisingly, Atov clearly showed a significant dose
dependent increase in percentage ‘free’ haem and de-
crease in percentage Hz (Fig. 11a, b). Although the in-
crease was less than that seen for both CQ and AQ at
Fig. 10 Haem fractionation profiles for pyrimethamine. Percentages of ‘free’ haem (a) and Hz (b) are shown at increasing concentrations of PYR.
No statistical difference exists between the total haem Fe per cell of all PYR treated cells and untreated cells (c). The amount of ‘free’ haem Fe (d)
and Hz Fe (e) are shown at increasing concentrations of PYR. PYR IC50 as determined in D10 = 44 ± 6.8 nM
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dose related. Further investigation however, revealed de-
creasing total haem Fe per trophozoite in Atov-treated
cells, showing that treated cells accumulated less haem
than control cells (Fig. 11c). This is in contrast to results
obtained for total haem Fe per trophozoite in both CQ
(Fig. 7d), AQ (Fig. 9d) and PYR (Fig. 10c) treated cells,
where cells treated with drug showed no significant dif-
ference to untreated cells. Despite the percentage in-
crease in ‘free’ haem with increasing Atov concentration,
when the amount of ‘free’ haem Fe per trophozoite
(fg/cell) was calculated, it was found to remain constant
with increasing dose, with no significant difference to the
control (5.4 ± 1.6 fg Fe/cell), at the 95 % CI. The decrease
in Hz is likely a result of decreased Hb uptake and di-
gestion secondary to treatment with this drug. This
result does, however, demonstrate the importance of
determining the total haem Fe per cell, using cell counts
determined with either a haemocytometer or FACS. In the
case of Atov, where the total haem Fe in treated cells wassignificantly less than the control (Fig. 11c), the percentage
values for each haem species are misleading (Fig. 11a and
b) and the amounts of each haem species per cell (Fig. 11d
and e) must be used. This approach demonstrated that
there was no change in ‘free’ haem and no relationship
with inhibition of parasite growth (Fig. 11f).
Conclusion
The successful adaptation of the haem fraction assay
from a very low throughput method with high demand
on valuable parasite starting material to a more efficient
process was achieved and validated using CQ as a
model. The improved throughput plate method is cap-
able of reproducing the results obtained with the flask
method using 24 times less starting material and in-
creasing output by at least six-fold. A fluorescent flow
cytometry-based technique for the determination of cell
counts of isolated trophozoites was also developed. This
new method of determining cell counts provided a faster
alternative to traditional manual methods of cell
Fig. 11 Haem fractionation profiles for atovaquone. Increase in percentage ‘free’ haem (a) and decrease in percentage Hz (b) seen with
increasing Atov concentration. The total haem Fe (fg) per trophozoite of Atov-treated cells is statistically different to untreated cells (c). Graphs d
and e show the amount of ‘free’ haem Fe (fg/cell) and Hz Fe per trophozoite respectively with increasing Atov concentration. The parasite survival
curve for Atov overlaid with the percentage of ‘free’ haem (grey graph with open triangles, right axis) shows an apparent rise in ‘free’ haem with
increasing Atov concentration correlated to parasite survival (f). However, by contrast to Hz inhibitors CQ and AQ, no relationship in fact exists
between parasite survival and the actual amount of ‘free’ haem Fe (fg/cell) per trophozoite (black dashed graph with closed squares, right axis)
which remains constant at 5.4 ± 0.4 fg haem Fe per cell. Atov IC50 as determined in D10 = 2.0 ± 0.8 nM
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several other established anti-malarials, providing rapid
and valuable insight into mechanistic action of anti-
malarials and has highlighted the important role which
haem plays in the action of several drugs. Results with
Atov emphasize the crucial importance of measuring
haem levels per cell rather than just percentages of haem
species in order to interpret the effects of drugs on para-
site haem concentrations. This approach is essential in
those cases where the total haem iron per cell changes
with drug dose. Applied to novel compounds, this
method will provide an important in vitro complement
to the existing detergent-mediated BH inhibition assay
in improving understanding of mechanism of action and
in exploring structure activity relationships and pros-
pects for rational drug design.
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